Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers

Background  Recent influenza antiviral resistance studies reveal an alarming increase in both adamantanes and neuraminidase inhibitors (NAIs) resistant viral strains worldwide, particularly in Asia, Europe and the United States.

• Publication year

  2009

• Venue

  Influenza and Other Respiratory Viruses

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1750-2659.2009.00072.xPMID 19496844PMCID 4634521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses

  2008cited by this paper
• Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries

  2008cited by this paper
• Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

  2008cited by this paper
• Het influenzaseizoen 2007/'08 in Nederland: antigene variatie, resistentie tegen oseltamivir en de vaccinsamenstelling voor het seizoen 2008/'09

  2008cited by this paper
• [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].

  2008cited by this paper
• Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

  2007cited by this paper
• The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.

  2007cited by this paper
• High prevalence of amantadine‐resistance influenza a (H3N2) in six prefectures, Japan, in the 2005–2006 Season

  2007cited by this paper
• How prepared is Europe for pandemic influenza?

  2006cited by this paper
• How prepared is Europe for pandemic influenza? Analysis of national plans.

  2006cited by this paper
• Oseltamivir Becomes Plentiful--But Still Not Cheap

  2006cited by this paper
• Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000.

  2006cited by this paper
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  2006cited by this paper
• Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

  2006cited by this paper
• Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

  2005cited by this paper
• Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls

  2005cited by this paper
• Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia.

  2005cited by this paper
• Influenza Virus Susceptibility and Resistance to Oseltamivir

  2005cited by this paper
• Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors

  2005cited by this paper
• Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

  2005cited by this paper
• Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

  2003cited by this paper
• Prostate Testing for Cancer and Treatment (ProtecT) feasibility study.

  2003cited by this paper
• Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient.

  2002cited by this paper
• Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs

  2002cited by this paper
• Antiviral therapy of influenza.

  2002cited by this paper
• Low incidence of rimantadine resistance in field isolates of influenza A viruses.

  1999cited by this paper
• Molecular basis of resistance of influenza A viruses to amantadine.

  1986cited by this paper
• Influenza

  1925cited by this paper

• Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies

  2023cites this paper
• In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein

  2018cites this paper
• Antiviral agents targeting the influenza virus: a review and publication analysis

  2018cites this paper
• Influenza Viruses, Biology, Epidemiology, and Control

  2017cites this paper
• Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches

  2017cites this paper
• Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.

  2016cites this paper
• Genomic Analysis of the Emergence, Evolution, and Spread of Human Respiratory RNA Viruses.

  2016cites this paper
• Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir.

  2015cites this paper
• Phylogenetic Tree and Antiviral Resistance Analysis of Neuraminidase Gene of Influenza A Virus in H1N1 Strains Found in 2010 and 2013

  2015cites this paper
• Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

  2015cites this paper
• The application of pseudotypes to influenza pandemic preparedness

  2015cites this paper
• Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?

  2015cites this paper
• Rates and effectiveness of antiviral use among hospitalized influenza patients

  2015cites this paper
• Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012

  2015influential citation
• Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

  2014cites this paper
• Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013

  2014influential citation
• Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.

  2013cites this paper
• Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006–2010

  2013cites this paper
• Severe influenza outbreak in Western Ukraine in 2009--a molecular-epidemiological study.

  2013cites this paper
• Rapid communications Oseltamivir-resistant influenza A ( H 1 N 1 ) pdm 09 virus in Dutch travellers returning from Spain , August 2012

  2012cites this paper
• Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012.

  2012cites this paper
• Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.

  2012cites this paper
• Réponse cellulaire pan-spécifique : analyse de la présentation d’antigènes conservés du virus de l’influenza

  2011cites this paper
• Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006–2010

  2011influential citation
• Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.

  2010cites this paper
• Genetic analysis of influenza A/H1N1 of swine origin virus (SOIV) circulating in Central and South America.

  2010cites this paper
• Influenza and other respiratory viruses in three Central American countries

  2010cites this paper
• Influenza in the tropics

  2010cites this paper
• Emergence of intratreatment resistance to oseltamivir in pandemic influenza a H1N1 2009 virus

  2010cites this paper
• Influenza-Like Illness Sentinel Surveillance in Peru

  2009cites this paper
• Oseltamivir resistance in swine influenza: a brief discussion

  2009cites this paper
• Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.

  2009cites this paper